NPPA demand notice of Rs 148.66 cr for alleged overcharging

Regulatory & Legal View source PDF Explain this filing

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹8110.00

prior close

₹8065.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-1.2% vs market

Pharmaceuticals peers, median of 164sector+0.1%-0.3% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.1

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+1.1-1.2+0.1-0.3

Next day

+2.3+2.4-0.1+1.1+1.2

+1.2+2.9-1.7+1.0+0.2

+0.0+4.2-4.2+1.1-1.1

-0.5+4.6-5.1+1.2-1.8

+1.1+4.6-3.5+1.5-0.4

-2.1+4.4-6.5+2.3-4.4

15d

-8.8+5.7-14.5+1.3-10.1

-14.3+6.6-20.9+2.3-16.6

-23.7+5.4-29.1+3.2-26.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NPPA has issued a demand notice of Rs 148.66 crores (inclusive of interest till Aug 20, 2026) against AstraZeneca Pharma India for alleged overcharging of Symbicort Turbuhaler 160/4.5 inhaler under DPCO 2013, covering May 2016 to November 2025. Payment is demanded within 30 days. The company is evaluating the notice and considering appropriate legal action.

Likely market impact

Potential liability of Rs 148.66 cr if demand is upheld; legal action likely. Near-term overhang on stock until resolved.